Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Click here to sign up for SAGE Journal Email Alerts today!
Journal of Child Neurology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Steiner, I.
Right arrow Articles by Dyken, P. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Steiner, I.
Right arrow Articles by Dyken, P. R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Intraventricular Interferon Treatment for Subacute Sclerosing Panencephalitis

I. Steiner, MD

Department of Neurology, Hadssah University Hospital and Hebrew University-Hadassah Medical School

I. Wirguin, MD

Department of Neurology, Hadssah University Hospital and Hebrew University-Hadassah Medical School

A. Morag, MD

Division of Clinical Virology, Hadassah University Hospital and Hebrew University-Hadassah Medical School, Jerusalem, Israel

O. Abramsky, MD, PhD

Department of Neurology, Hadssah University Hospital and Hebrew University-Hadassah Medical School

Paul R. Dyken, MD

Department of Neurology, Hadssah University Hospital and Hebrew University-Hadassah Medical School

Three children with subacute sclerosing panencephalitis (SSPE) were treated with alpha-interferon. Medication was administered via an Ommaya reservoir into the cerebral ventricular system over a period of 13 to 24 months in increasing amounts up to 1.0 X 106 IU twice weekly. Mild clinical improvement in two children and a stable course in the third were associated with improvement of electroencephalographic recordings in all patients and a decrease in antimeasles antibodies in the cerebrospinal fluid of two. The small number of patients does not enable us to determine whether this course was the natural history of SSPE in our patients or whether it was induced by treatment, yet it seems that intraventricular interferon treatment can modify the course of SSPE. ( J Child Neurol 1989;4:20-23).

Journal of Child Neurology, Vol. 4, No. 1, 20-24 (1989)
DOI: 10.1177/088307388900400103
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 NEJMHome page
A. J. Cole, J. W. Henson, M. H.A. Roehrl, and M. P. Frosch
Case 24-2007 -- A 20-Year-Old Pregnant Woman with Altered Mental Status
N. Engl. J. Med., August 9, 2007; 357(6): 589 - 600.
[Full Text] [PDF]

Home page
 NeurologyHome page
I. Wirguin, T. Vander, T. Brenner, O. Abramsky, I. Steiner, E. Matsubara, T. Kurata, M. Yokoyama, I. Nagano, M. Shoji, et al.
Improvement of SSPE by intrathecal infusion of {alpha}-IFN
Neurology, January 25, 2005; 64(2): 402 - 402.
[Full Text] [PDF]

Home page
 J Child NeurolHome page
I. Steiner, I. Wirguin, A. Morag, O. Abramsky, and P. R. Dyken
Intraventricular Interferon Treatment for Subacute Sclerosing Panencephalitis
J Child Neurol, January 1, 1989; 4(1): 20 - 24.
[Abstract] [PDF]